Q1 2024 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
AstraZeneca (AZN) shares jump on much stronger Q1 top and bottom line
April 25, 2024 5:50 AM EDTAstraZeneca (NASDAQ: AZN) shares rose 5.1% in London trading Thursday after the drugmaker smashed analyst expectations for Q1 earnings and revenue.
The company posted earnings per share (EPS) of $2.06, beating the consensus estimates of $1.10. Revenue stood at $12.68 billion, also above the estimated $11.79... More
